Invesco QQQ, CyberArk Software, UnitedHealth Group, Marvell Technology, Novo Nordisk A/S, Boeing, and ProShares UltraPro Short QQQ are the seven Value stocks to watch today, according to MarketBeat's stock screener tool. Value stocks are shares of companies that appear to be trading for less than their intrinsic or book value, often measured by low price-to-earnings or price-to-book ratios. Investors buy them in the hope that the market will recognize their true worth over time, leading to price appreciation. These companies are typically mature, with stable earnings and sometimes higher-than-average dividend yields. These companies had the highest dollar trading volume of any Value stocks within the last several days.
Invesco QQQ (QQQ)
PowerShares QQQ Trust, Series 1 is a unit investment trust that issues securities called Nasdaq-100 Index Tracking Stock. The Trust's investment objective is to provide investment results that generally correspond to the price and yield performance of the Nasdaq-100 Index. The Trust provides investors with the opportunity to purchase units of beneficial interest in the Trust representing proportionate undivided interests in the portfolio of securities held by the Trust, which consists of substantially all of the securities, in substantially the same weighting, as the component securities of the Nasdaq-100 Index.
Invesco QQQ stock traded up $0.38 during midday trading on Wednesday, reaching $567.64. The company's stock had a trading volume of 32,492,273 shares, compared to its average volume of 44,551,703. Invesco QQQ has a 52-week low of $402.39 and a 52-week high of $572.11. The stock's 50-day simple moving average is $541.00 and its 200-day simple moving average is $509.58.
Read Our Latest Research Report on QQQ
CyberArk Software (CYBR)
CyberArk Software Ltd., together with its subsidiaries, develops, markets, and sells software-based identity security solutions and services in the United States, Europe, the Middle East, Africa, and internationally. Its solutions include Privileged Access Manager, which offers risk-based credential security and session; Vendor Privileged Access Manager combines Privileged Access Manager and Remote Access to provide secure access to third-party vendors; Dynamic Privileged Access, a SaaS solution that provides just-in-time access to Linux Virtual Machines; Endpoint Privilege Manager, a SaaS solution that secures privileges on the endpoint; and Secure Desktop, a solution that protects access to endpoints.
Shares of CYBR stock traded up $0.27 during trading hours on Wednesday, reaching $434.75. 12,913,968 shares of the company's stock were exchanged, compared to its average volume of 781,741. The company has a market cap of $21.49 billion, a P/E ratio of -232.22 and a beta of 1.00. CyberArk Software has a 1 year low of $230.00 and a 1 year high of $452.00. The company's 50 day moving average is $388.96 and its two-hundred day moving average is $366.53.
Read Our Latest Research Report on CYBR
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Shares of NYSE UNH traded up $5.13 during midday trading on Wednesday, hitting $266.20. 19,076,832 shares of the company's stock were exchanged, compared to its average volume of 11,651,425. The stock's 50 day moving average price is $299.69 and its 200-day moving average price is $421.43. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group has a twelve month low of $248.88 and a twelve month high of $630.73. The firm has a market cap of $241.48 billion, a P/E ratio of 11.13, a PEG ratio of 1.40 and a beta of 0.45.
Read Our Latest Research Report on UNH
Marvell Technology (MRVL)
Marvell Technology, Inc., together with its subsidiaries, provides data infrastructure semiconductor solutions, spanning the data center core to network edge. The company develops and scales complex System-on-a-Chip architectures, integrating analog, mixed-signal, and digital signal processing functionality.
Shares of NASDAQ MRVL traded up $5.47 during mid-day trading on Wednesday, hitting $81.81. 39,424,646 shares of the stock were exchanged, compared to its average volume of 18,729,607. Marvell Technology has a twelve month low of $47.08 and a twelve month high of $127.48. The company has a market cap of $70.67 billion, a P/E ratio of -143.24, a PEG ratio of 0.82 and a beta of 1.81. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.94 and a current ratio of 1.30. The stock's fifty day simple moving average is $70.51 and its two-hundred day simple moving average is $76.83.
Read Our Latest Research Report on MRVL
Novo Nordisk A/S (NVO)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
NVO traded down $3.91 on Wednesday, reaching $50.03. The company had a trading volume of 57,874,540 shares, compared to its average volume of 10,217,817. Novo Nordisk A/S has a fifty-two week low of $49.60 and a fifty-two week high of $139.74. The stock has a market cap of $223.38 billion, a P/E ratio of 14.80, a P/E/G ratio of 1.33 and a beta of 0.64. The company's fifty day moving average is $70.43 and its 200 day moving average is $73.37. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.56 and a current ratio of 0.74.
Read Our Latest Research Report on NVO
Boeing (BA)
The Boeing Company, together with its subsidiaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight and launch systems, and services worldwide. The company operates through Commercial Airplanes; Defense, Space & Security; and Global Services segments.
NYSE:BA traded down $0.19 during trading hours on Wednesday, reaching $225.89. The company had a trading volume of 7,680,461 shares, compared to its average volume of 8,619,898. The business's 50-day simple moving average is $214.01 and its two-hundred day simple moving average is $187.68. Boeing has a twelve month low of $128.88 and a twelve month high of $242.69. The firm has a market cap of $170.32 billion, a price-to-earnings ratio of -12.60 and a beta of 1.41.
Read Our Latest Research Report on BA
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
Shares of SQQQ traded down $0.01 during mid-day trading on Wednesday, reaching $18.16. The company's stock had a trading volume of 87,273,793 shares, compared to its average volume of 90,957,016. ProShares UltraPro Short QQQ has a 52 week low of $17.72 and a 52 week high of $57.95. The company's fifty day moving average price is $21.15 and its two-hundred day moving average price is $28.69.
Read Our Latest Research Report on SQQQ
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Invesco QQQ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Invesco QQQ wasn't on the list.
While Invesco QQQ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
